Publications by authors named "Maria Diez-Rodriguez"

23Publications

The combined expression of solute carriers is associated with a poor prognosis in highly proliferative ER+ breast cancer.

Breast Cancer Res Treat 2019 May 22;175(1):27-38. Epub 2019 Jan 22.

Nottingham Breast Cancer Research Centre, Division of Cancer and Stem Cells, School of Medicine, Nottingham City Hospital, University of Nottingham, Hucknall Road, Nottingham, NG5 1PB, UK.

View Article and Find Full Text PDF
May 2019

Glutamate dehydrogenase (GLUD1) expression in breast cancer.

Breast Cancer Res Treat 2019 Feb 23;174(1):79-91. Epub 2018 Nov 23.

Nottingham Breast Cancer Research Centre, Division of Cancer and Stem Cells, School of Medicine, University of Nottingham, Hucknall Road, Nottingham, NG5 1PB, UK.

View Article and Find Full Text PDF
February 2019

Co-expression of nuclear P38 and hormone receptors is prognostic of good long-term clinical outcome in primary breast cancer and is linked to upregulation of DNA repair.

BMC Cancer 2018 Oct 23;18(1):1027. Epub 2018 Oct 23.

Nottingham Breast Cancer Research Centre, Division of Cancer and Stem Cells, School of Medicine, The University of Nottingham, Nottingham, UK.

View Article and Find Full Text PDF
October 2018

Kinesin family member-18A (KIF18A) is a predictive biomarker of poor benefit from endocrine therapy in early ER+ breast cancer.

Breast Cancer Res Treat 2019 Jan 10;173(1):93-102. Epub 2018 Oct 10.

Nottingham Breast Cancer Research Centre, Division of Cancer and Stem Cells, School of Medicine, Nottingham City Hospital, University of Nottingham, Hucknall Road, Nottingham, NG5 1PB, UK.

View Article and Find Full Text PDF
January 2019

Saccharomyces cerevisiae-like 1 (SEC14L1) is a prognostic factor in breast cancer associated with lymphovascular invasion.

Mod Pathol 2018 11 28;31(11):1675-1682. Epub 2018 Jun 28.

Division of Cancer and Stem Cells, School of Medicine, University of Nottingham and Nottingham University Hospital NHS Trust, Nottingham City Hospital, Nottingham, UK.

View Article and Find Full Text PDF
November 2018

Thioredoxin-interacting protein is an independent risk stratifier for breast ductal carcinoma in situ.

Mod Pathol 2018 12 28;31(12):1807-1815. Epub 2018 Jun 28.

Academic Pathology, Division of Cancer and Stem Cells, School of Medicine, The University of Nottingham, Nottingham City Hospital, Nottingham, UK.

View Article and Find Full Text PDF
December 2018

Heterogeneity of tumour-infiltrating lymphocytes in breast cancer and its prognostic significance.

Histopathology 2018 Dec 9;73(6):887-896. Epub 2018 Oct 9.

Nottingham Breast Cancer Research Centre, Division of Cancer and Stem Cells, School of Medicine, University of Nottingham, Nottingham City Hospital, Nottingham, UK.

View Article and Find Full Text PDF
December 2018

Mediator complex (MED) 7: a biomarker associated with good prognosis in invasive breast cancer, especially ER+ luminal subtypes.

Br J Cancer 2018 04 28;118(8):1142-1151. Epub 2018 Mar 28.

Division of Cancer and Stem Cells, School of Medicine, University of Nottingham and Nottingham University Hospitals NHS Trust, City Hospital Campus, Nottingham, NG5 1PB, UK.

View Article and Find Full Text PDF
April 2018

The amino acid transporter SLC7A5 confers a poor prognosis in the highly proliferative breast cancer subtypes and is a key therapeutic target in luminal B tumours.

Breast Cancer Res 2018 03 22;20(1):21. Epub 2018 Mar 22.

Academic Pathology, Division of Cancer and Stem Cells, School of Medicine, University of Nottingham, Nottingham City Hospital, Hucknall Road, Nottingham, NG5 1PB, UK.

View Article and Find Full Text PDF
March 2018

The multifunctional solute carrier 3A2 (SLC3A2) confers a poor prognosis in the highly proliferative breast cancer subtypes.

Br J Cancer 2018 04 16;118(8):1115-1122. Epub 2018 Mar 16.

Academic Pathology, Division of Cancer and Stem Cells, School of Medicine, Nottingham City Hospital, University of Nottingham, Hucknall Road, Nottingham, NG5 1PB, UK.

View Article and Find Full Text PDF
April 2018

MYC regulation of glutamine-proline regulatory axis is key in luminal B breast cancer.

Br J Cancer 2018 01 23;118(2):258-265. Epub 2017 Nov 23.

Academic Pathology, Division of Cancer and Stem Cells, School of Medicine, University of Nottingham, Nottingham City Hospital, Hucknall Road, Nottingham NG5 1PB, UK.

View Article and Find Full Text PDF
January 2018

Ki67 expression in invasive breast cancer: the use of tissue microarrays compared with whole tissue sections.

Breast Cancer Res Treat 2017 Jul 6;164(2):341-348. Epub 2017 May 6.

Department of Histopathology, Division of Cancer and Stem Cells, School of Medicine, Nottingham City Hospital, The University of Nottingham and Nottingham University Hospitals NHS Trust, Nottingham, UK.

View Article and Find Full Text PDF
July 2017

Phenotypic characterisation of breast cancer: the role of CDC42.

Breast Cancer Res Treat 2017 Jul 27;164(2):317-325. Epub 2017 Apr 27.

Division of Cancer and Stem Cells, School of Medicine, University of Nottingham and Nottingham University Hospitals NHS Trust, City Hospital Campus, Nottingham, NG5 1PB, UK.

View Article and Find Full Text PDF
July 2017

Prognostic significance of tumour infiltrating B lymphocytes in breast ductal carcinoma in situ.

Histopathology 2017 Aug 26;71(2):258-268. Epub 2017 May 26.

Division of Cancer and Stem Cells, School of Medicine, The University of Nottingham and Nottingham University Hospitals NHS Trust, Nottingham City Hospital, Nottingham, UK.

View Article and Find Full Text PDF
August 2017

Further evidence to support bimodality of oestrogen receptor expression in breast cancer.

Histopathology 2017 Feb 28;70(3):456-465. Epub 2016 Nov 28.

Division of Cancer and Stem Cells, School of Medicine, The University of Nottingham and Nottingham University Hospitals NHS Trust, Nottingham City Hospital, Nottingham, UK.

View Article and Find Full Text PDF
February 2017

Prognostic significance of androgen receptor expression in invasive breast cancer: transcriptomic and protein expression analysis.

Breast Cancer Res Treat 2016 Sep 11;159(2):215-27. Epub 2016 Aug 11.

Division of Cancer and Stem Cells, Molecular Pathology Research Unit, School of Medicine, University of Nottingham and Nottingham University Hospitals NHS Trust, City Hospital Campus, Nottingham, NG5 1PB, UK.

View Article and Find Full Text PDF
September 2016

The prognostic significance of STAT3 in invasive breast cancer: analysis of protein and mRNA expressions in large cohorts.

Breast Cancer Res Treat 2016 Feb 23;156(1):9-20. Epub 2016 Feb 23.

Division of Cancer and Stem Cells, School of Medicine, University of Nottingham and Nottingham University Hospitals NHS Trust, City Hospital Campus, Nottingham, NG5 1PB, UK.

View Article and Find Full Text PDF
February 2016

Clinical utility of reverse phase protein array for molecular classification of breast cancer.

Breast Cancer Res Treat 2016 Jan 9;155(1):25-35. Epub 2015 Dec 9.

Department of Histopathology, Division of Cancer and Stem Cells, School of Medicine, The University of Nottingham, Nottingham, UK.

View Article and Find Full Text PDF
January 2016

Markers of progression in early-stage invasive breast cancer: a predictive immunohistochemical panel algorithm for distant recurrence risk stratification.

Breast Cancer Res Treat 2015 Jun 8;151(2):325-33. Epub 2015 May 8.

Molecular Pathology Research Unit, Division of Cancer and Stem Cells, School of Medicine, University of Nottingham, Nottingham, UK,

View Article and Find Full Text PDF
June 2015